Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ACAD [NASD]
ACADIA Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.44 Insider Own0.10% Shs Outstand98.46M Perf Week-2.99%
Market Cap1.91B Forward P/E- EPS next Y-0.57 Insider Trans23.33% Shs Float98.24M Perf Month-31.55%
Income-37.90M PEG- EPS next Q-0.14 Inst Own85.50% Short Float11.52% Perf Quarter-19.87%
Sales1.10M P/S1740.06 EPS this Y-15.80% Inst Trans0.68% Short Ratio5.09 Perf Half Y-20.81%
Book/sh2.00 P/B9.72 EPS next Y6.60% ROA-21.70% Target Price31.50 Perf Year59.61%
Cash/sh1.89 P/C10.30 EPS next 5Y20.00% ROE-24.30% 52W Range11.26 - 32.00 Perf YTD-22.21%
Dividend- P/FCF- EPS past 5Y24.00% ROI-21.00% 52W High-39.25% Beta3.51
Dividend %- Quick Ratio26.90 Sales past 5Y-7.20% Gross Margin- 52W Low72.65% ATR1.81
Employees48 Current Ratio26.90 Sales Q/Q-90.30% Oper. Margin- RSI (14)38.96 Volatility11.22% 8.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-18.20% Profit Margin- Rel Volume0.97 Prev Close19.28
ShortableYes LT Debt/Eq0.00 EarningsMay 05 Payout- Avg Volume2.22M Price19.44
Recom2.00 SMA20-12.99% SMA50-22.10% SMA200-15.93% Volume2,154,196 Change0.83%
07-Aug-13Reiterated Needham Buy $16 → $26
07-Aug-13Reiterated Ladenburg Thalmann Buy $15 → $24
07-Aug-13Downgrade MLV & Co Buy → Hold $18 → $20
11-Apr-13Reiterated Needham Buy $9 → $16
11-Apr-13Reiterated MLV & Co Buy $12.50 → $18
11-Apr-13Reiterated Ladenburg Thalmann Buy $9 → $15
13-Mar-13Reiterated Ladenburg Thalmann Buy $8 → $9
28-Nov-12Reiterated MLV & Co Buy $4.50 → $8.50
27-Nov-12Upgrade Needham Hold → Buy $9
27-Nov-12Reiterated Ladenburg Thalmann Buy $8
30-Apr-12Initiated Ladenburg Thalmann Buy
01-Sep-09Downgrade Citigroup Hold → Sell
05-May-09Upgrade JMP Securities Mkt Perform → Mkt Outperform $7
06-Aug-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
08-Jul-08Upgrade Banc of America Sec Sell → Neutral
17-Jun-08Downgrade Jefferies & Co Buy → Hold $14 → $4
17-Jun-08Downgrade Friedman Billings Outperform → Mkt Perform $21 → $8
17-Jun-08Downgrade Banc of America Sec Buy → Sell
06-May-08Reiterated Brean Murray Sell $7 → $6
07-Mar-08Reiterated Fortis Bank Buy $22 → $23
16-Apr-14 03:00PM  Is this March 2000? at MarketWatch +5.01%
15-Apr-14 12:23PM  The Recent Performance of 'Baker Brother Biotech Stocks' is Awful at TheStreet
11-Apr-14 05:08PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01-Apr-14 09:00AM  ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference on April 8, 2014 Business Wire
28-Mar-14 04:58PM  3 Biotech Stocks Trading The Wrong Direction In March at Seeking Alpha
18-Mar-14 12:13PM  Puritan Fund's Flexible Approach to Investing Leads to Emphasis on U.S. Equities: A Wall Street Transcript Interview with Ramin Arani, a Portfolio Manager at Fidelity Management & Research Company Wall Street Transcript
11-Mar-14 05:06PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
10-Mar-14 12:16PM  Insider Trading Alert - ACAD, FOSL And GPRE Traded By Insiders at TheStreet
07-Mar-14 09:06AM  ACADIA price target raised to $42 from $28 at Piper Jaffray theflyonthewall.com
09:06AM  ACADIA price target raised to $42 from $28 at Piper Jaffray
06-Mar-14 01:04PM  ACADIA PHARMACEUTICALS INC Financials EDGAR Online Financials
05-Mar-14 04:23PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
06:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
04-Mar-14 07:28PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire +6.56%
07:28PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock
03-Mar-14 04:02PM  ACADIA files to sell $150M in common stock at theflyonthewall.com
04:02PM  ACADIA files to sell $150M in common stock
04:01PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire
04:01PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
01-Mar-14 09:34AM  An Update On Acadia Pharmaceuticals at Seeking Alpha
09:34AM  An Update On Acadia Pharmaceuticals
28-Feb-14 02:04PM  Cynapsus Represents A Compelling Acquisition Target For Acadia Pharmaceuticals at Seeking Alpha -5.98%
11:55AM  ACADIA Pharmaceuticals (ACAD) Is Water-Logged And Getting Wetter Today at TheStreet
27-Feb-14 08:50PM  ACADIA Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  ACADIA Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today CCBN
04:04PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013 Business Wire
07:34AM  ACADIA Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today CCBN
07:07AM  Q4 2013 ACADIA Pharmaceuticals Earnings Release - After Market Close CCBN
26-Feb-14 02:31PM  Acadia Pharmaceuticals: Here's What You Should Know About Its Surging Shares at Motley Fool
24-Feb-14 01:43AM  ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% Zacks
21-Feb-14 11:19AM  Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) at TheStreet +17.33%
20-Feb-14 09:00AM  ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 Business Wire
11-Feb-14 08:31AM  Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming at Seeking Alpha
05-Feb-14 12:00PM  Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options at TheStreet
30-Jan-14 06:36PM  Lightning Round: Altria, Gogo & More at CNBC
23-Jan-14 09:05AM  Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 at Seeking Alpha
21-Jan-14 08:31AM  Upside in biotech, cloud, materials? optionMONSTER
08:31AM  Upside in biotech, cloud, materials?
20-Jan-14 08:31AM  Upside in biotech, cloud, materials? optionMONSTER
08:31AM  Upside in biotech, cloud, materials?
13-Jan-14 04:08PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:08PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
07-Jan-14 10:08AM  Healthcare Stocks To Avoid This Year at Seeking Alpha
10:08AM  Healthcare Stocks To Avoid This Year
07:33AM  This tiny mutual fund is no. 1 for 2013 at MarketWatch
07:33AM  This tiny mutual fund is no. 1 for 2013
06-Jan-14 11:52AM  Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days at Seeking Alpha
11:52AM  Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days
02-Jan-14 09:44AM  The Best- And Worst-Performing Biotech Stocks Of 2013 at Forbes
09:44AM  The Best- And Worst-Performing Biotech Stocks Of 2013
01-Jan-14 10:26AM  Biggest Winners in Health Care Last Week at Motley Fool
10:26AM  Biggest Winners in Health Care Last Week
09:13AM  Biotech 2013 by the Numbers: A Blockbuster Year at TheStreet
09:13AM  Biotech 2013 by the Numbers: A Blockbuster Year
30-Dec-13 01:15PM  [video] Russell stocks up 400 percent in 2013 at CNBC
01:15PM  [video] Russell stocks up 400 percent in 2013
12:27PM  Taking A Look At A Few Of The Top Performers Of 2013 at Seeking Alpha
09:19AM  The Billion-Dollar Biotech Club: Speculation Trumped Risk at TheStreet
08:30AM  The Billion-Dollar Biotech Club: Speculation Trumped Risk at TheStreet
28-Dec-13 04:43PM  ACADIA Pharmaceuticals Inc: The Best Performing Biotechs of 2013 at Motley Fool
04:43PM  ACADIA Pharmaceuticals Inc: The Best Performing Biotechs of 2013
27-Dec-13 04:21PM  Acadia: The Best Hope For Parkinson's Psychosis Sufferers at Seeking Alpha
04:21PM  Acadia: The Best Hope For Parkinson's Psychosis Sufferers
19-Dec-13 08:01AM  Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond at Seeking Alpha
11-Dec-13 06:31PM  Understanding The Investment Opportunity In Developmental Biotechnology at Seeking Alpha -5.55%
04:44PM  Lessons Learned From The Top 20 Stocks Of 2013 at Seeking Alpha
10:48AM  3 Drugmakers to Watch in the New Year at Motley Fool
09-Dec-13 07:04PM  Biggest Winners in Biotech This Year at Motley Fool
06:56PM  2013's Top Performers at Seeking Alpha
11:46AM  Treating Parkinson's Disease Psychosis at Motley Fool
04-Dec-13 01:17PM  Why Acadia Is A Promising Investment at Seeking Alpha
03-Dec-13 03:18PM  ACADIA Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) at Seeking Alpha
26-Nov-13 09:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
25-Nov-13 11:20AM  2 Biotech Stocks With Strong Buyout Potential at Wall St. Cheat Sheet
09:47AM  2 Biotech Stocks With Strong Buyout Potential at Wall St. Cheat Sheet
23-Nov-13 09:25AM  The Best- And Worst-Performing Biotech Stocks, Nov. 15 to Nov. 22 at Forbes
22-Nov-13 05:11PM  3 Drugmakers on the Move at Motley Fool
21-Nov-13 01:32PM  [video] Biotech index hits an all-time high at CNBC +6.34%
18-Nov-13 09:12AM  Should Johnson & Johnson Bet On An Antipsychotic Acquisition? at Seeking Alpha -7.88%
17-Nov-13 10:23AM  Amarin, Sarepta And Vanda: Teachable Moments In Biotech at Seeking Alpha
14-Nov-13 01:04PM  ACADIA PHARMACEUTICALS INC Financials EDGAR Online Financials
09:00AM  ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimers Disease Psychosis Business Wire
12-Nov-13 10:00AM  Acaida's Pimavanserin Is The Next Blockbuster For Psychosis at Seeking Alpha
10:00AM  Acadia's Pimavanserin Is The Next Blockbuster For Psychosis at Seeking Alpha
08-Nov-13 04:58PM  Boom Or Bubble? Insiders Like The Look Of These 3 Biotech Stocks at TheStreet
01:54PM  Pimavanserin Calls For Better Valuations For Acadia at Seeking Alpha
08:56AM  Key Issues Surrounding The Zalicus Catalyst Trade at Seeking Alpha
07:00AM  ACAD: Pimavanserin Development Remains On Track Zacks Small Cap Research
07-Nov-13 09:45AM  Today's Dead Cat Bounce Stock Is ACADIA Pharmaceuticals (ACAD) at TheStreet
06-Nov-13 08:40PM  ACADIA Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha -7.28%
05:00PM  ACADIA Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today CCBN
04:55PM  ACADIA Pharmaceuticals Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
04:06PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results Business Wire
07:07AM  Q3 2013 ACADIA Pharmaceuticals Earnings Release - After Market Close CCBN
04-Nov-13 06:59PM  Lightning round: Wolverine World Wide and more at CNBC
12:34PM  ACADIA Pharmaceuticals Loss Expected to Widen at Forbes
11:45AM  The Next Great Growth Companies On Big Pharma's Radar at Seeking Alpha
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by Pimavanserin that is in the Phase III development as a first-in-class treatment for Parkinson's disease psychosis, and in Phase II development for Alzheimer's disease psychosis; and has completed Phase II trial as a co-therapy for schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hacksell UliCEOApr 15Option Exercise6.9525,000173,75025,000Apr 17 06:00 PM
Hacksell UliCEOApr 15Sale17.7525,000443,835115,549Apr 17 06:00 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Option Exercise1.557,50011,62538,848Apr 04 07:51 PM
Rasmussen TorstenDirectorApr 04Option Exercise2.4030,00072,07538,500Apr 04 07:52 PM
Brege LauraDirectorApr 04Option Exercise1.7514,28524,99914,285Apr 04 07:52 PM
Brege LauraDirectorApr 04Sale22.5414,285321,9250Apr 04 07:52 PM
Rasmussen TorstenDirectorApr 04Sale21.9830,000659,3858,500Apr 04 07:52 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Sale22.4815,000337,2600Apr 04 07:51 PM
BAKER BROS. ADVISORS LPDirectorMar 05Buy28.50526,31615,000,00618,476,847Mar 07 05:27 PM
Baity GlennVP AND GCFeb 26Option Exercise6.1742,000259,14089,788Feb 28 05:48 PM
Baity GlennVP AND GCFeb 26Sale30.2842,0001,271,71847,788Feb 28 05:48 PM
Hacksell UliCEOFeb 18Option Exercise6.9525,000173,75025,000Feb 20 06:29 PM
Hacksell UliCEOFeb 18Sale24.1425,000603,528115,549Feb 20 06:29 PM
Hacksell UliCEOJan 15Option Exercise6.9525,000173,75025,000Jan 17 05:43 PM
Brege LauraDirectorJan 15Option Exercise1.3610,00013,60010,000Jan 17 05:43 PM
Brege LauraDirectorJan 15Sale24.1810,000241,7640Jan 17 05:43 PM
Hacksell UliCEOJan 15Sale24.0125,000600,288115,549Jan 17 05:43 PM
Aasen Thomas HEXEC VP, CFO AND CBOJan 02Option Exercise1.5522,00034,10061,348Jan 03 07:03 PM
Iversen Leslie LDirectorJan 02Option Exercise1.7460,000104,23073,500Jan 03 07:04 PM
Iversen Leslie LDirectorJan 02Sale25.0360,0001,501,75213,500Jan 03 07:04 PM
Aasen Thomas HEXEC VP, CFO AND CBOJan 02Sale24.8830,000746,3340Jan 03 07:03 PM
Hacksell UliCEODec 17Option Exercise1.556,50010,0756,500Dec 18 07:03 PM
Aasen Thomas HEXEC VP, CFO AND CBODec 12Option Exercise2.0012,00024,00039,348Dec 16 05:43 PM
Brege LauraDirectorDec 10Option Exercise1.3644,11759,99944,117Dec 12 06:15 PM
Brege LauraDirectorDec 10Sale23.4144,1171,032,9110Dec 12 06:15 PM
Hacksell UliCEODec 02Option Exercise2.0015,00030,00015,000Dec 04 06:11 PM
Hacksell UliCEODec 02Sale23.4515,000351,807109,049Dec 04 06:11 PM
Hacksell UliCEONov 01Option Exercise2.0015,00030,00015,000Nov 01 07:59 PM
Rasmussen TorstenDirectorNov 01Option Exercise1.3037,69249,00046,192Nov 01 07:59 PM
Rasmussen TorstenDirectorNov 01Sale23.0037,692867,0338,500Nov 01 07:59 PM
Hacksell UliCEONov 01Sale23.2415,000348,638109,049Nov 01 07:59 PM
Brege LauraDirectorOct 10Option Exercise1.3010,00013,00010,000Oct 11 05:35 PM
Brege LauraDirectorOct 10Sale21.6310,000216,2560Oct 11 05:35 PM
Aasen Thomas HEXEC VP, CFO AND CBOOct 01Option Exercise2.7522,50061,87554,085Oct 03 06:35 PM
Aasen Thomas HEXEC VP, CFO AND CBOOct 01Sale27.8730,000836,1210Oct 03 06:35 PM
Mills RogerEVP, DEVELOPMENT AND CMOSep 20Option Exercise0.0035,965051,740Sep 20 06:52 PM
Mills RogerEVP, DEVELOPMENT AND CMOSep 20Sale25.0135,965899,31215,775Sep 20 06:52 PM
KAPLAN LESTER J PH DDirectorSep 12Option Exercise4.3766,356289,82374,856Sep 13 05:53 PM
Iversen Leslie LDirectorSep 12Option Exercise1.6660,00099,60073,500Sep 13 05:56 PM
Iversen Leslie LDirectorSep 12Sale22.9260,0001,375,47013,500Sep 13 05:56 PM
KAPLAN LESTER J PH DDirectorSep 12Sale22.9066,3561,519,6728,500Sep 13 05:53 PM
Brege LauraDirectorSep 10Option Exercise1.3046,15359,99946,153Sep 12 06:05 PM
Brege LauraDirectorSep 10Sale22.8046,1531,052,1450Sep 12 06:05 PM
Rasmussen TorstenDirectorSep 03Option Exercise1.5240,00060,60048,500Sep 05 06:14 PM
Rasmussen TorstenDirectorSep 03Sale20.2840,000811,1008,500Sep 05 06:14 PM
GRAY MARY ANNDirectorAug 26Option Exercise8.2215,000123,25015,000Aug 28 07:04 PM
GRAY MARY ANNDirectorAug 26Sale20.6815,000310,2110Aug 28 07:04 PM
Aasen Thomas HEXEC VP, CFO AND CBOAug 13Option Exercise1.5545,00069,75091,585Aug 15 06:58 PM
Hacksell UliCEOAug 13Option Exercise1.0852,77156,99352,771Aug 15 06:59 PM
Hacksell UliCEOAug 13Sale20.1452,7711,063,061109,049Aug 15 06:59 PM
Aasen Thomas HEXEC VP, CFO AND CBOAug 13Sale20.1560,0001,209,1800Aug 15 06:58 PM
BAKER FELIXDirectorJun 05Buy14.51872,58512,657,99918,001,203Jun 05 06:47 PM
BAKER FELIXDirectorJun 04Buy14.45699,77610,110,69317,240,358Jun 05 06:47 PM
BAKER FELIXDirectorJun 03Buy14.06767,95310,794,61516,630,193Jun 05 06:47 PM
BAKER FELIXDirectorMay 15Buy12.501,993,00024,912,50015,960,582May 17 04:10 PM
Hacksell UliCEOMay 02Option Exercise1.0820,44922,08520,449May 03 06:08 PM
Hacksell UliCEOMay 02Sale12.3420,449252,396109,049May 03 06:08 PM
Hacksell UliCEOMay 01Option Exercise1.0819,55121,11519,551May 03 06:08 PM
Hacksell UliCEOMay 01Sale12.7119,551248,519109,049May 03 06:08 PM
Baity GlennVP AND GCApr 22Option Exercise1.6210,00016,20050,000Apr 24 05:56 PM
Baity GlennVP AND GCApr 22Sale13.1510,000131,49340,000Apr 24 05:56 PM